Québec International, corporation de développement économique pour la région de QuébecQuébec International, corporation de développement économique pour la région de Québec

News

OPSENS Moves FFR Activities to Increase Manufacturing Capacity

News - Opsens Inc. announces that in light of the positive feedback on the performance of its products developed to measure Fractional Flow Reserve ("FFR"), the OptoWire and OptoMonitor ("Opsens' FFR products"), and the recent FDA approval for the commercialization of these products in the U.S., the Company is going forward with a massive expansion to increase the manufacturing capacity and accommodate its growing number of employees.

handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities.

News - handyem Inc. and FlowMetric Diagnostics Inc. announce their partnership centralized around the incorporation of handyem’s HPC-150 portable flow cytometer within FlowMetric Diagnostics’ , the Mo-POD™. This unprecedented model of mobile laboratory platform is presented at the BIO International Conference at the Pennsylvania Convention Center, Philadelphia from June 15th to 18th 2015.

Opsens gets clearance to sell FFR products in the United States

News - Opsens Inc. today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the OptoWire and OptoMonitor, its products developed to measure Fractional Flow Reserve (“FFR”). This measure is used to optimize the diagnostic and guide the treatment of patients with coronary heart disease. This clearance gives Opsens permission to sell its FFR products in the United States, the world’s largest FFR market.

LeddarTech introduces LeddarCore sensor ICs for high-volume applications

News - LeddarTech® today announced the upcoming launch of LeddarCore™, a new line of sensor ICs designed to offer unmatched integration capabilities for the development and production of high-volume applications.

Cloud services: Microsoft chooses Québec City for one of its data centres

News - Québec International welcomes the announcement by American giant Microsoft to provide commercial cloud services from Québec City and Toronto.

New portal for Canadian clinical research capabilities launched: CCTAM

News - The Canadian Clinical Trials Asset Map (CCTAM), a pan-Canadian database showcasing Canada’s clinical research capacities was launched this morning in front of an audience of scientists, researchers and policymakers, by Senator Kelvin K. Ogilvie.

Sweet dreams: Quebec chocolate entrepreneur aiming for global expansion

News - Is Dominique Brown the world’s coolest dad? His kids must certainly think so. A decade after he sold Beenox, a video-game development company he founded in 2000 at age 21, to multinational giant Activision for megabucks, the Quebec City entrepreneur is now investing his time and money in a unique chocolate-making company.

Aeterna Zentaris and EMD Serono Finalize Promotional Services Agreement for Saizen® (Somatropin (rDNA origin) for Injection) in the U.S.

News - Aeterna Zentaris Inc. and EMD Serono, Inc., the U.S. and Canadian biopharmaceutical businesses of Merck KGaA, Darmstadt, Germany, today announced the finalization of a promotional services agreement that will allow Aeterna Zentaris to promote Saizen® [somatropin (rDNA origin) for injection] to designated medical professionals in specified territories in the United States. Saizen® is a recombinant human Growth Hormone (r-hGH) registered in the U.S. for the treatment of growth hormone deficiency (GHD) in children and adults.

Opsens announces first use of its FFR products by Dr. Nico Pijls

News - Opsens inc. is pleased to announce the first use of the OptoWire and OptoMonitor, its products to measure Fractional Flow Reserve ("FFR"), by Dr. Nico Pijls in Eindhoven, the Netherlands. Opsens' FFR products are designed to optimize the diagnosis and guide the treatment of patients with coronary heart disease.

DiagnoCure's new prostate cancer multimarker urine test featured at a recent press event of the American Urological Association

News - DiagnoCure Inc.reports that the results of the prospective trial on its prostate cancer panel (PCP) urine test were well received by the urologist community attending the 2015 Annual Meeting of the American Urological Association (AUA) held from May 15 to May 19 in New Orleans, Louisiana.

Newsletter

Subscribe to our newsletter for interesting news and information.

Print this page